133 related articles for article (PubMed ID: 21129661)
1. [Postoperative radiotherapy for prostate cancer].
Vieillot S; Fenoglietto P; Ailleres N; Hay MH; Dubois JB; Azria D
Cancer Radiother; 2010 Nov; 14 Suppl 1():S174-81. PubMed ID: 21129661
[TBL] [Abstract][Full Text] [Related]
2. [Prostate cancer].
Vieillot S; Fenoglietto P; Aillères N; Hay MH; Dubois JB; Azria D
Cancer Radiother; 2010 Nov; 14 Suppl 1():S161-73. PubMed ID: 21129660
[TBL] [Abstract][Full Text] [Related]
3. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
5. Dose-escalated 3D conformal radiotherapy in prostate cancer.
Malone S
Expert Rev Anticancer Ther; 2004 Aug; 4(4):663-8. PubMed ID: 15270669
[TBL] [Abstract][Full Text] [Related]
6. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
7. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
8. Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy.
Jereczek-Fossa BA; Zerini D; Fodor C; Santoro L; Serafini F; Cambria R; Vavassori A; Cattani F; Garibaldi C; Gherardi F; Ferrari A; Rocco B; Scardino E; de Cobelli O; Orecchia R
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):26-34. PubMed ID: 20133085
[TBL] [Abstract][Full Text] [Related]
9. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
[TBL] [Abstract][Full Text] [Related]
10. A phase I trial of pre-operative radiotherapy for prostate cancer: clinical and translational studies.
Supiot S; Shubbar S; Fleshner N; Warde P; Hersey K; Wallace K; Cole H; Sweet J; Tsihlias J; Jewett MA; Klotz L; Bristow RG
Radiother Oncol; 2008 Jul; 88(1):53-60. PubMed ID: 18423916
[TBL] [Abstract][Full Text] [Related]
11. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
Michalski JM; Winter K; Purdy JA; Perez CA; Ryu JK; Parliament MB; Valicenti RK; Roach M; Sandler HM; Markoe AM; Cox JD
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):735-42. PubMed ID: 14967428
[TBL] [Abstract][Full Text] [Related]
12. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy.
Hanks GE; Hanlon AL; Pinover WH; Horwitz EM; Schultheiss TE
Cancer J Sci Am; 1999; 5(3):152-8. PubMed ID: 10367171
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of clinically localized prostate cancer. Part III--external beam radiotherapy].
Gisterek I; Szelachowska J; Kornafel J
Pol Merkur Lekarski; 2006 Dec; 21(126):602-6. PubMed ID: 17405307
[TBL] [Abstract][Full Text] [Related]
14. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy.
Zelefsky MJ; Marion C; Fuks Z; Leibel SA
J Urol; 2003 Nov; 170(5):1828-32. PubMed ID: 14532785
[TBL] [Abstract][Full Text] [Related]
15. Results of three dimensional conformal radiotherapy and hormonal therapy for local recurrence after radical prostatectomy.
Schwarz R; Krüll A; Tribius S; Alberti W
Strahlenther Onkol; 2005 Jul; 181(7):442-7. PubMed ID: 15995837
[TBL] [Abstract][Full Text] [Related]
16. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
Peeters ST; Heemsbergen WD; van Putten WL; Slot A; Tabak H; Mens JW; Lebesque JV; Koper PC
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1019-34. PubMed ID: 15752881
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome in patients with prostate cancer treated with external beam radiotherapy and high dose-rate iridium 192 brachytherapy boost: a 6-year follow-up.
Kälkner KM; Wahlgren T; Ryberg M; Cohn-Cedermark G; Castellanos E; Zimmerman R; Nilsson J; Lundell M; Fowler J; Levitt S; Hellström M; Nilsson S
Acta Oncol; 2007; 46(7):909-17. PubMed ID: 17917823
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of radiation dose escalation with conformal external beam radiotherapy and high-dose-rate brachytherapy combined with long-term androgen suppression in unfavorable prostate cancer: feasibility report.
Valero J; Cambeiro M; Galán C; Teijeira M; Romero P; Zudaire J; Moreno M; Ciérvide R; Aristu JJ; Martínez-Monge R
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):386-92. PubMed ID: 19427741
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary results for EORTC trial 22911: radical prostatectomy followed by postoperative radiotherapy in prostate cancers with a high risk of progression].
Bolla M; Van Poppel H; Collette L;
Cancer Radiother; 2007 Nov; 11(6-7):363-9. PubMed ID: 17931949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]